Literature DB >> 32567032

miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process.

Huiqing Wang1, Xiaoyu Shi2, Shanbin Wu3.   

Abstract

In this study, the functional role of miR-550a-3 and its direct target nuclear factor IC (NFIC) in esophageal squamous cell cancer (ESCC) cells were explored. Differential expression of miR-550a-3 in ESCC tissues was acquired from TCGA database, and Kaplan-Meier method was used to determine the relationship between miR-550a-3 expression and survival time of ESCC patients. Expression level of miR-550a-3 in several ESCC cell lines was measured by qRT-PCR. Two cell lines including Eca109 and JAR were used to perform proliferation, cloning, invasion and migration experiments. Targeted relationship between miR-550a-3 and NFIC was speculated by predication software and confirmed by dual luciferase assay. Additionally, potential relationship between miR-550a-3 and NFIC was analyzed by Spearman rank correlation analysis and western blot. Rescue assays were performed to explore the function of miR-550a-3/NFIC in ESCC cells biological behaviors. Expression levels of key proteins involved in epithelial-to-mesenchymal transition (EMT) process were determined by western blot. By consulting TCGA database, we found that high expression of miR-550a-3 was positively connected with the poor prognosis of patients with ESCC. In addition, overexpression of miR-550a-3 promoted the proliferation, colony formation and metastasis of ESCC cells. Moreover, rescue assays revealed that overexpression of NFIC attenuated the promoting effects of miR-550a-3 on ESCC cells malignant behaviors. While the promoting effects of miR-550a-3 on EMT process were inhibited by NFIC. Our results illustrate the importance of miR-550a-3/NFIC in regulation of ESCC cells growth and metastasis, which could contribute to developing novel target for early diagnosis or neoteric therapeutic target for ESCC.

Entities:  

Keywords:  Aggressiveness; Esophageal squamous cell cancer; NFIC; Proliferation; miR-550a-3

Mesh:

Substances:

Year:  2020        PMID: 32567032     DOI: 10.1007/s11010-020-03790-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  4 in total

1.  PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma.

Authors:  Sarah D Edge; Isaline Renard; Emily Pyne; Chun Li; Hannah Moody; Rajarshi Roy; Andrew W Beavis; Stephen J Archibald; Christopher J Cawthorne; Stephen G Maher; Isabel M Pires
Journal:  Br J Radiol       Date:  2021-01-12       Impact factor: 3.039

2.  MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis.

Authors:  Fengxia Chen; Qingqing Wang; Xiaoyan Yu; Ningning Yang; Yuan Wang; Yangyang Zeng; Zhewen Zheng; Fuxiang Zhou; Yunfeng Zhou
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

3.  Prognostic and Predictive Value of Transcription Factors Panel for Digestive System Carcinoma.

Authors:  Guoxu Fang; Jianhui Fan; Zongren Ding; Rong Li; Kongying Lin; Jun Fu; Qizhen Huang; Yongyi Zeng; Jingfeng Liu
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

4.  Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.

Authors:  Xuyang Liang; Zhimei Zhang; Lu Wang; Shuxian Zhang; Ling Ren; Shouying Li; Jing Xu; Shengxiang Lv
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.